Sarcoma: open trials in China

• NCT04433221

  Combination Immunotherapy Targeting Sarcomas

  Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute

  Shenzhen Geno-immune Medical Institute, Shenzhen

  Registry updated 2026-11-02

• NCT03356782

  Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

  Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute

  Shenzhen Geno-immune Medical Institute, Shenzhen

  Registry updated 2026-10-30

• NCT07902011

  CTEPH Differential Diagnosis Assisted by Enhanced Large Language Model Support

  Trial Treatment · China-Japan Friendship Hospital

  China-Japan Friendship Hospital, Beijing

  Registry updated 2026-10-29

• NCT04557449

  Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

  Trial Treatment · Phase 1/2 · Pfizer

  Cancer Hospital Chinese Academy of Medical Science, Beijing · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · Hubei Cancer Hospital, Wuhan · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · Henan Cancer Hospital, Zhengzhou

  Registry updated 2026-10-28

• NCT06345729

  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Beijing Cancer hospital ( Site 3134), Beijing · Beijing Peking Union Medical College Hospital-pneumology department ( Site 3102), Beijing · Beijing Cancer hospital ( Site 3133), Beijing · Beijing Chest Hospital,Capital Medical University ( Site 3104), Beijing · Jilin Province Tumor Hospital ( Site 3107), Changchun · The Second Xiangya Hospital of Central South University ( Site 3130), Changsha · Hunan Cancer Hospital ( Site 3141), Changsha · Sichuan Cancer hospital. ( Site 3109), Chengdu · The Third People's Hospital of Chengdu (CDTPH) ( Site 3157), Chengdu · West China Hospital, Sichuan University ( Site 3140), Chengdu · Chongqing University Cancer Hospital ( Site 3119), Chongqing · Army Medical Center of People's Liberation Army ( Site 3142), Chongqing · Fujian Cancer Hospital ( Site 3127), Fuzhou · Southern Medical University Nanfang Hospital ( Site 3128), Guangzhou · Sun Yat-sen University Cancer Center ( Site 3137), Guangzhou · The First Affiliated Hospital of Guangzhou Medical University ( Site 3108), Guangzhou · The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115), Hangzhou · Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3121), Hangzhou · Harbin Medical University Cancer Hospital ( Site 3123), Harbin · Anhui Provincial Cancer Hospital ( Site 3136), Hefei · JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 3124), Jiamusi · Shandong Cancer Hospital ( Site 3116), Jinan · Yunnan Province Cancer Hospital ( Site 3153), Kunming · Taizhou Hospital of Zhejiang Province ( Site 3145), Linhai · LinYi Cancer Hospital ( Site 3111), Linyi · The Second Affiliated Hospital of Nanchang University ( Site 3139), Nanchang · The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 3138), Nanchang · Nanjing Gulou Hospital ( Site 3122), Nanjing · Nanjing First Hospital ( Site 3154), Nanjing · The Second People's Hospital of Neijiang ( Site 3105), Neijiang · Shanghai Chest Hospital ( Site 3100), Shanghai · Fudan University Shanghai Cancer Center ( Site 3144), Shanghai · Zhongshan Hospital,Fudan University ( Site 3143), Shanghai · The First Affiliated Hospital of Soochow University ( Site 3146), Suzhou · Shanxi Cancer Hospital ( Site 3131), Taiyuan · Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3101), Ürümqi · The First Affiliated Hospital of Wenzhou Medical University ( Site 3151), Wenzhou · Tongji Hospital Tongji Medical,Science & Technology ( Site 3113), Wuhan · Hubei Cancer Hospital ( Site 3126), Wuhan · Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3155), Wuxi · The First Affiliated hospital of Xiamen University ( Site 3148), Xiamen · The First Affiliated Hospital of Xi'an Jiaotong University ( Site 3150), Xi'an · The Second Affiliated Hospital of Air Force Medical University ( Site 3152), Xian · The Second Affiliated Hospital of Air Force Medical University ( Site 3117), Xian · Henan Cancer Hospital ( Site 3149), Zhengzhou

  Registry updated 2026-10-26

• NCT06531486

  A Phase I Study of XS-02 Capsules in Patients With Advanced Solid Tumors

  Trial Treatment · Phase 1 · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

  Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

  Registry updated 2026-10-26

• NCT06932861

  Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma

  Trial Treatment · Early phase 1 · Xinxin Zhang

  Chinese PLA General Hospital, Beijing

  Registry updated 2026-10-26

• NCT07888114

  Preliminary Clinical Study of Entinostat in Children With Malignant Soft Tissue Sarcoma Harboring PAX-family Gene Abnormalities

  Trial Treatment · Phase 1 · Beijing Tongren Hospital

  Beijing Tongren Hospital, Beijing

  Registry updated 2026-10-22

• NCT06980259

  Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma

  Trial Treatment · Shandong Cancer Hospital and Institute

  Shandong Cancer Hospital and Institute, Jinan

  Registry updated 2026-10-13

• NCT07541170

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Guangdong General Hospital, Guangzhou

  Registry updated 2026-10-13

• NCT07129005

  Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids

  Research · Tongji Hospital

  Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

  Registry updated 2026-10-08

• NCT06760819

  A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  Trial Treatment · Phase 2 · Bayer

  Beijing Cancer Hospital - Oncology Department, Beijing · Peking University First Hospital - Oncology Department, Beijing · Hunan Cancer Hospital - Oncology Department, Changsha · Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou · Zhongshan Hospital,Fudan University, Shanghai · Fudan University Shanghai Cancer Center - Oncology Department, Shanghai

  Registry updated 2026-10-02

• NCT06884618

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

  Trial Treatment · Phase 1 · Hoffmann-La Roche

  Sun Yat-Sen University Cancer Center - Huangpu Campus, Guangzhou · Sun Yat-Sen University Cancer Center;Department of Thoracic Surgery, Guangzhou · Fudan University Shanghai Cancer Center, Shanghai · Hubei Cancer Hospital, Wuhan

  Registry updated 2026-09-28

• NCT07842276

  Utidelone Capsules Combined With Doxorubicin for Advanced Soft Tissue Sarcoma

  Trial Treatment · Phase 2 · Beijing Biostar Pharmaceuticals Co., Ltd.

  West China Hospital，Sichuan University, Chengdu

  Registry updated 2026-09-25

• NCT06926283

  A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors

  Trial Treatment · Phase 1 · Hangzhou DAC Biotechnology Co., Ltd.

  Peking University First Hospital, Beijing · Peking University People's Hospital, Beijing · Hunan Cancer Hospital, Changsha · Zhejiang Provincial People's Hospital, Hangzhou

  Registry updated 2026-09-23

• NCT07817095

  SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma

  Trial Treatment · Phase 2 · Tianjin Medical University Cancer Institute and Hospital

  Tianjin Medical University Cancer Institute & Hospital, Tianjin

  Registry updated 2026-09-14

• NCT07459283

  The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

  Trial Treatment · Early phase 1 · FindCure Biosciences (ZhongShan) Co., Ltd.

  Affiliated Hospital of Jiangnan University, Wuxi

  Registry updated 2026-09-04

• NCT07252739

  KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  West China Hospital, Sichuan University ( Site 0315), Chengdu · The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 0306), Nanchang · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 0318), Nanjing · Zhongshan Hospital Fudan University ( Site 0319), Shanghai

  Registry updated 2026-09-02

• NCT07774533

  68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma

  Trial Treatment · Early phase 1 · Peking University First Hospital

  Peking University First Hospital, Beijing

  Registry updated 2026-08-19

• NCT07725783

  Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma

  Research · Peking University People's Hospital

  Peking University People's Hospital, Beijing, Beijing 100044, Beijing

  Registry updated 2026-07-24

• NCT07374848

  Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

  Trial Treatment · Phase 1 · Zai Lab (Shanghai) Co., Ltd.

  Cancer Hospital, Chinese Academy of Medical Sciences, Beijing · Shanghai East Hospital, Shanghai

  Registry updated 2026-07-23

• NCT07575724

  Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity Sarcoma

  Trial Treatment · Phase 2 · Second Affiliated Hospital, Zhejiang University, School of Medicine

  Hangzhou Third People's Hospital, Hangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

  Registry updated 2026-07-14

• NCT07244835

  A Study of DEG6498 in Participants With Solid Tumors

  Trial Treatment · Phase 1 · Degron Therapeutics Co.

  Beijing Cancer Hospital, Beijing · Beijing GoBroad Hospital, Beijing · Sun Yat-sen University Cancer Center, Guangzhou

  Registry updated 2026-06-30

• NCT07648069

  Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma

  Trial Treatment · Phase 1 · Sun Yat-sen University

  Sun Yat-sen University Cancer Center, Guangzhou

  Registry updated 2026-06-15

• NCT04589741

  Toripalimab Combined With CAV/IE Regimen

  Trial Treatment · Phase 2 · Sun Yat-sen University

  Sun Yat-sen University Cancer Center, Guangzhou

  Registry updated 2026-06-12

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error